Douglas Jermasek Unicycive Therapeutics, Inc. (UNCY) insider trading activity

UNCY Quotes by TradingView

Douglas Jermasek is EVP of Corporate Strategy of Unicycive Therapeutics, Inc.. Currently has a direct ownership of 175,012 shares of UNCY, which is worth approximately $87,506. The most recent transaction as insider was on Jul 11, 2023, when has been sold 104,612 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 175K
0% 3M change
0% 12M change
Total Value Held $87,506

Douglas Jermasek Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 11 2023
BUY
Exercise of conversion of derivative security
-
104,612 Added 37.41%
175,012 Common Stock
DJ

Douglas Jermasek

EVP of Corporate Strategy
Los Altos, CA

Track Institutional and Insider Activities on UNCY

Follow Unicycive Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UNCY shares.

Notify only if

Insider Trading

Get notified when an Unicycive Therapeutics, Inc. insider buys or sells UNCY shares.

Notify only if

News

Receive news related to Unicycive Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on UNCY